Elevated circulating HHIP levels in patients with metabolic syndrome

Area of Science:

• Biochemistry
• Genetics
• Metabolic Disorders

Background:

• Abnormal fat accumulation is linked to metabolic syndrome (MetS), increasing risks for diabetes and cardiovascular disease.
• Early identification of MetS risk is crucial for effective disease prevention strategies.

Purpose of the Study:

• To identify novel biomarkers for metabolic syndrome (MetS) using bioinformatics approaches.
• To investigate the diagnostic and predictive potential of identified biomarkers in MetS patients.

Main Methods:

• Bioinformatic analysis of gene expression datasets (GSE9624, GSE15524, GSE65540).
• Quantitative PCR and immunoblotting to validate gene expression in mouse models.
• Population-based cohort study and ROC curve analysis to assess serum HHIP levels in MetS patients.

Main Results:

• Three differentially expressed genes (COX7A1, PRR12, HHIP) were identified; HHIP expression was significantly elevated in MetS indicators.
• Serum HHIP levels were significantly higher in MetS patients and correlated with all MetS components.
• HHIP demonstrated robust predictive capacity for MetS (AUC=0.72) and was independently associated with MetS.

Conclusions:

• HHIP is significantly associated with adverse metabolic syndrome indicators.
• HHIP serves as a promising novel biomarker for the diagnosis of metabolic syndrome.